This prediction can be tested in other cancers with early p53 inactivation and precursor conditions, including serous ovarian cancers16, basal breast cancers, uterine serous endometrial cancers, pancreatic cancers59, and colitis-associated colorectal cancers15. The gene discussed is TP53; the disease is cancer.